Evidence map›Paper›PMID 36700580›Full record

ArticleMemorias do Instituto Oswaldo Cruz2023

Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon.

Gabriella Sgorlon, Jackson Alves da Silva Queiroz, Tárcio Peixoto Roca, Ana Maisa Passos da Silva, Nadson Willian Felipe Gasparelo, Karolaine Santos Teixeira, Andreia Souza da Nóbrega Oliveira, Aline Linhares Ferreira de Melo Mendonça, Adriana Cristina Salvador Maia, Soraya Dos Santos Pereira and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Ophthalmic Manifestations Among Patients Surviving COVID-19.International journal of general medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Gabriella SgorlonFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.
Jackson Alves da Silva QueirozFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.
Tárcio Peixoto RocaFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.
Ana Maisa Passos da SilvaFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.
Nadson Willian Felipe GaspareloFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.
Karolaine Santos TeixeiraFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.
Andreia Souza da Nóbrega OliveiraLaboratório Central de Saúde Pública do Estado de Rondônia, Porto Velho, RO, Brasil.
Aline Linhares Ferreira de Melo MendonçaLaboratório Central de Saúde Pública do Estado de Rondônia, Porto Velho, RO, Brasil.
Adriana Cristina Salvador MaiaLaboratório Central de Saúde Pública do Estado de Rondônia, Porto Velho, RO, Brasil.
Soraya Dos Santos PereiraFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.
Flávia Serrano BatistaAgência Estadual de Vigilância em Saúde de Rondônia, Coordenação Estadual da Covid-19, Porto Velho, RO, Brasil.
Juan Miguel Villalobos SalcedoFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.
Rita de Cassia Pontello RampazzoInstituto de Biologia Molecular do Paraná, Curitiba, PR, Brasil.
Paola Cristina ResendeFundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios e do Sarampo, Rio de Janeiro, RJ, Brasil.
Marilda Mendonça SiqueiraFundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Vírus Respiratórios e do Sarampo, Rio de Janeiro, RJ, Brasil.
Felipe Gomes NavecaFundação Oswaldo Cruz, Instituto Leônidas e Maria Deane, Laboratório de Virologia, Manaus, AM, Brasil.
Deusilene VieiraFundação Oswaldo Cruz, Laboratório de Virologia Molecular, Porto Velho, RO, Brasil.ORCID http://orcid.org/0000-0001-9817-724X
Universidade Federal de Rondônia · BRFundação Oswaldo Cruz · BRInstituto de Saúde · BRInstituto de Biologia Molecular do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has become a major concern contributing to increased morbidity and mortality worldwide.

objectivesHere we describe the replacement of the Gamma variant of concern (VOC) with Delta in the western Brazilian Amazon.

methodsIn this study, we analysed 540 SARS-CoV-2 positive samples determined by qualitative real-time RT-PCR selected in the state of Rondônia between June and December 2021. The positive cohort was sequenced through next-generation sequencing (NGS) and each sample was quantified using real-time RT-qPCR, the whole genome sequence was obtained, SARS-CoV-2 lineages were classified using the system Pango and the maximum likelihood (ML) method was used to conduct phylogenetic analyses.

findingsA total of 540 high-quality genomes were obtained, where the Delta VOC showed the highest prevalence making up 72%, with strain AY.43 being the most abundant, while the Gamma VOC was present in 28%, where the P.1 strain was the most frequent. In this study population, only 32.96% (178/540) had completed the vaccination schedule. MAIN

conclusionsThis study highlighted the presence of Gamma and Delta variants of SARS-CoV-2 in RO. Furthermore, we observed the replacement of the Gamma VOC with the Delta VOC and its lineages.

Indexed as

COVID-19BrazilHumansPhylogenySARS-CoV-2

Identifiers

PMID36700580
PMCPMC9870256
OpenAlexW4318166006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.